Oridonin enhances TRAIL-induced apoptosis through GALNT14-mediated DR5 glycosylation

This publication has 24 references indexed in Scilit:

• A new oridonin analog suppresses triple-negative breast cancer cells and tumor growth via the induction of death receptor 5
  Cancer Letters, 2016
• Oridonin inhibits the proliferation of human colon cancer cells by upregulating BMP7 to activate p38 MAPK
  Oncology Reports, 2016
• Reactive oxygen species mediate oridonin-induced apoptosis through DNA damage response and activation of JNK pathway in diffuse large B cell lymphoma
  Leukemia & Lymphoma, 2015
• Spatial dynamics of TRAIL death receptors in cancer cells
  Drug Resistance Updates, 2015
• Oridonin Induces Apoptosis, Inhibits Migration and Invasion on Highly-Metastatic Human Breast Cancer Cells
  The American Journal of Chinese Medicine, 2013
• What can molecular pathology contribute to the management of renal cell carcinoma?
  Nature Reviews Urology, 2011
• Molecular biology of Bax and Bak activation and action
  Biochimica et Biophysica Acta (BBA) - Molecular Cell Research, 2011
• c-Cbl-mediated degradation of TRAIL receptors is responsible for the development of the early phase of TRAIL resistance
  Cellular Signalling, 2010
• Death-receptor O-glycosylation controls tumor-cell sensitivity to the proapoptotic ligand Apo2L/TRAIL
  Nature Medicine, 2007
• Differential control of growth, cell cycle progression, and expression of NF-κB in human breast cancer cells MCF-7, MCF-10A, and MDA-MB-231 by ponicidin and oridonin, diterpenoids from the chinese herb Rabdosia rubescens
  Biochemical and Biophysical Research Communications, 2005